Ronald Marcus
Overview
Ronald Marcus received an average of $486K in total compensation, including $308K in salary, at Avalo Therapeutics from 2015 to 2017.
Source: SEC filings on April 5, 2018 and April 8, 2016.
Related executives
We found 16 more executives who work or worked at Avalo Therapeutics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Simon Pedder
Avalo Therapeutics
Chairman
Pericles Calias
Avalo Therapeutics